• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西参考中心囊性纤维化患者中洋葱伯克霍尔德菌复合体。

Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.

机构信息

Department of Pediatrics, School of Medical Sciences, University of Campinas, P.O. Box: 6111, Campinas, SP, 13081-970, Brazil.

Department of Medical Genetics, School of Medical Sciences, University of Campinas, P.O. Box: 6111, Campinas, SP, 13081-970, Brazil.

出版信息

Med Microbiol Immunol. 2017 Dec;206(6):447-461. doi: 10.1007/s00430-017-0521-2. Epub 2017 Sep 30.

DOI:10.1007/s00430-017-0521-2
PMID:28965239
Abstract

The Burkholderia cepacia complex (BCC) can cause a severe decline in lung function in cystic fibrosis (CF). Our objective was to determine the BCC prevalence and to evaluate its clinical impact on CF. Clinical and laboratory variables were determined for CF patients with BCC (Group-A = 50 patients) and without BCC (Group-B = 134 patients). The microorganisms were identified by biochemical tests, the Vitek2Compact test, recA-PCR and recA-nested-PCR with species-specific primers and DNA sequencing. The patients were evaluated by the Shwachman-Kulczycki score (SKCS), Bhalla score (BS), spirometry and body mass index (BMI). The BCC prevalence was 22.5%. The most common species were Burkholderia multivorans (30%), Burkholderia cepacia (24%), Burkholderia cenocepacia IIIA (10%), B. cenocepacia IIIB (2%) and Burkholderia vietnamiensis (2%). There was difference between the groups in nutritional status (p = 0.02) and general activity (p = 0.026). There was difference in total BS points (p = 0.04) and the following parameters: bronchiectasis severity (p = 0.007), peribronchial thickening (p = 0.013), bronchiectasis extent (p = 0.01) and general aspects of the affected bronchial zone (p = 0.02). The respiratory disorder classifications were as follows: obstructive-4.8% (Group-A) and 23.8% (Group-B); restrictive-9.5% (Group-A and Group-B); obstructive + restrictive-19% (Group-A) and 1.6% (Group-B); and obstructive + restrictive with a decreased forced expiratory flow-47.6% (Group-A) and 30.2% (Group-B) (p = 0.02). Nutritional status was a minor contributing factor to weight, height and BMI in the Group-A (p = 0.02). The BCC prevalence, particularly the prevalence of B. multivorans, was higher in this study. The SKCS, BS, spirometry and nutritional status results showed that BCC has a negative impact on clinical status. Phenotypic methods are useful for the identification of presumptive BCC. The Vitek2Compact test showed accuracy in BCC identification. PCR, nested-PCR, and recA sequencing showed specificity in BCC species identification.

摘要

洋葱伯克霍尔德菌复合群(BCC)可导致囊性纤维化(CF)患者的肺功能严重下降。本研究旨在确定 BCC 的流行率,并评估其对 CF 的临床影响。对患有 BCC 的 CF 患者(A 组=50 例)和无 BCC 的 CF 患者(B 组=134 例)进行临床和实验室变量测定。采用生化试验、Vitek2Compact 试验、recA-PCR 和 recA 巢式-PCR 联合种特异性引物和 DNA 测序对微生物进行鉴定。通过 Shwachman-Kulczycki 评分(SKCS)、Bhalla 评分(BS)、肺量测定和体重指数(BMI)对患者进行评估。BCC 的流行率为 22.5%。最常见的物种是伯克霍尔德菌多噬亚种(30%)、洋葱伯克霍尔德菌(24%)、洋葱伯克霍尔德菌 Cenocepacia IIIA(10%)、Cenocepacia IIIB(2%)和越南伯克霍尔德菌(2%)。两组间在营养状况(p=0.02)和一般活动能力(p=0.026)方面存在差异。总 BS 评分(p=0.04)和以下参数存在差异:支气管扩张严重程度(p=0.007)、支气管周围增厚(p=0.013)、支气管扩张程度(p=0.01)和受累支气管区域的一般方面(p=0.02)。呼吸障碍分类如下:阻塞性-4.8%(A 组)和 23.8%(B 组);限制性-9.5%(A 组和 B 组);阻塞性+限制性-19%(A 组)和 1.6%(B 组);阻塞性+限制性伴呼气流量降低-47.6%(A 组)和 30.2%(B 组)(p=0.02)。营养状况是 A 组体重、身高和 BMI 的次要影响因素(p=0.02)。BCC 的流行率,特别是伯克霍尔德菌多噬亚种的流行率,在本研究中更高。SKCS、BS、肺量测定和营养状况结果表明,BCC 对临床状况有负面影响。表型方法有助于鉴定推定的 BCC。Vitek2Compact 试验在 BCC 鉴定方面具有准确性。PCR、巢式 PCR 和 recA 测序在 BCC 种鉴定方面具有特异性。

相似文献

1
Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.巴西参考中心囊性纤维化患者中洋葱伯克霍尔德菌复合体。
Med Microbiol Immunol. 2017 Dec;206(6):447-461. doi: 10.1007/s00430-017-0521-2. Epub 2017 Sep 30.
2
Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.英国囊性纤维化和非囊性纤维化患者中伯克霍尔德菌属(包括洋葱伯克霍尔德菌复合体成员)的患病率。
J Med Microbiol. 2017 Apr;66(4):490-501. doi: 10.1099/jmm.0.000458.
3
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.意大利一家囊性纤维化中心的患者中洋葱伯克霍尔德菌复合体感染的流行病学及临床病程,特别是由不同洋葱伯克霍尔德菌菌株引起的感染。
J Clin Microbiol. 2004 Apr;42(4):1491-7. doi: 10.1128/JCM.42.4.1491-1497.2004.
4
Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.从囊性纤维化患者中分离出的洋葱伯克霍尔德菌、多食伯克霍尔德菌、栖稻伯克霍尔德菌和越南伯克霍尔德菌菌株具有不同的胞外酶产生谱。
APMIS. 2007 Apr;115(4):311-8. doi: 10.1111/j.1600-0463.2007.apm_603.x.
5
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.囊性纤维化患者中洋葱伯克霍尔德菌复合体定植的流行病学
Eur Respir J. 2004 Jun;23(6):851-6. doi: 10.1183/09031936.04.00118804.
6
Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis.从患有囊性纤维化的儿童中分离出的洋葱伯克霍尔德菌复合体菌种的多相特征分析。
Mem Inst Oswaldo Cruz. 2016 Jan;111(1):37-42. doi: 10.1590/0074-02760150314.
7
Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation.从囊性纤维化患者中分离出的洋葱伯克霍尔德菌复合体菌种的流行病学:与患者隔离相关的问题。
J Med Microbiol. 2004 Jul;53(Pt 7):663-668. doi: 10.1099/jmm.0.45557-0.
8
Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.准确鉴定囊性纤维化痰液中洋葱伯克霍尔德菌复合体的成员。
Lett Appl Microbiol. 2016 Mar;62(3):221-9. doi: 10.1111/lam.12537. Epub 2016 Feb 2.
9
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.囊性纤维化患者感染洋葱伯克霍尔德菌复合群基因变种:基因变种III的强毒可传播菌株可取代多食伯克霍尔德菌。
Clin Infect Dis. 2001 Nov 1;33(9):1469-75. doi: 10.1086/322684. Epub 2001 Oct 4.
10
Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid.马德里一家成人囊性纤维化病房中的洋葱伯克霍尔德菌复合体感染
Enferm Infecc Microbiol Clin. 2013 Dec;31(10):649-54. doi: 10.1016/j.eimc.2012.12.001. Epub 2013 Mar 23.

引用本文的文献

1
Right lung agenesis with multi-drug-resistant Cepacia syndrome: A case report.右肺发育不全合并多重耐药洋葱伯克霍尔德菌综合征:一例报告。
J Family Med Prim Care. 2025 Feb;14(2):804-806. doi: 10.4103/jfmpc.jfmpc_1424_24. Epub 2025 Feb 21.
2
Quality of anthropometric data measured in children and adolescents with cystic fibrosis: a scoping review.儿童和青少年囊性纤维化患者人体测量数据的质量:范围综述。
Rev Paul Pediatr. 2023 Mar 3;41:e2021333. doi: 10.1590/1984-0462/2023/41/2021333. eCollection 2023.
3
Case Report: Community-Acquired Burkholderia cepacia Pneumonia of a Patient with Pulmonary Tuberculosis.

本文引用的文献

1
Report - Prevalence of hospital acquired Burkholderia cepacia infection and its antimicrobial susceptibility in a Chinese hospital.报告 - 中国一家医院中医院获得性洋葱伯克霍尔德菌感染的患病率及其抗菌药敏情况
Pak J Pharm Sci. 2017 Mar;30(2):551-553.
2
Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.洋葱伯克霍尔德菌复合体的联合抗菌药敏试验:种属的意义。
Int J Antimicrob Agents. 2016 Nov;48(5):521-527. doi: 10.1016/j.ijantimicag.2016.07.020. Epub 2016 Sep 12.
3
Antibiotic resistance in Burkholderia species.
病例报告:肺结核患者社区获得性伯克霍尔德菌肺炎。
Am J Trop Med Hyg. 2022 Jun 13;107(1):86-88. doi: 10.4269/ajtmh.21-1338. Print 2022 Jul 13.
伯克霍尔德菌属的抗生素耐药性。
Drug Resist Updat. 2016 Sep;28:82-90. doi: 10.1016/j.drup.2016.07.003. Epub 2016 Jul 30.
4
Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials.多药外排泵作为固有和获得性抗微生物药物耐药的主要参与者。
Drug Resist Updat. 2016 Sep;28:13-27. doi: 10.1016/j.drup.2016.06.007. Epub 2016 Jun 30.
5
Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis.从患有囊性纤维化的儿童中分离出的洋葱伯克霍尔德菌复合体菌种的多相特征分析。
Mem Inst Oswaldo Cruz. 2016 Jan;111(1):37-42. doi: 10.1590/0074-02760150314.
6
Performance of MALDI-ToF MS for species identification of Burkholderia cepacia complex clinical isolates.基质辅助激光解吸电离飞行时间质谱技术对洋葱伯克霍尔德菌复合体临床分离株进行种属鉴定的性能评估。
Diagn Microbiol Infect Dis. 2013 Oct;77(2):126-8. doi: 10.1016/j.diagmicrobio.2013.06.011. Epub 2013 Jul 23.
7
Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere.伯克霍尔德氏菌假多样亚种,一种新型洋葱伯克霍尔德氏菌复合群物种,分离自人类呼吸道样本和根际。
Syst Appl Microbiol. 2013 Oct;36(7):483-9. doi: 10.1016/j.syapm.2013.06.003. Epub 2013 Jul 16.
8
Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?感染洋葱伯克霍尔德菌复合体的囊性纤维化患者是否应被列入肺移植名单?
Interact Cardiovasc Thorac Surg. 2011 Dec;13(6):631-4. doi: 10.1510/icvts.2011.271874. Epub 2011 Sep 14.
9
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.分类单元K是洋葱伯克霍尔德菌复合群中的一个复合体,包含至少两个新物种,即污染伯克霍尔德菌新种和宽伯克霍尔德菌新种。
Int J Syst Evol Microbiol. 2009 Jan;59(Pt 1):102-11. doi: 10.1099/ijs.0.001123-0.
10
[Chronic bacterial infection and echocardiographic parameters indicative of pulmonary hypertension in patients with cystic fibrosis].[慢性细菌感染与囊性纤维化患者中提示肺动脉高压的超声心动图参数]
J Bras Pneumol. 2008 Jul;34(7):461-7. doi: 10.1590/s1806-37132008000700005.